8-K/A XBRL

FORM 8-K/A

Company: ABVC BIOPHARMA, INC.
Filed: May 30, 2025
Period of Report: April 30, 2025
Accession Number: 0001213900-25-049491

View Document ↗ View on SEC.gov ↗